See more news releases in: Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, New Products & Services
Acella Pharmaceuticals, LLC, Files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration
ATLANTA, Feb. 21, 2012 /PRNewswire/ -- Acella Pharmaceuticals, LLC, recently announced that it has filed an abbreviated new drug application (ANDA) for a product in the upper respiratory therapeutic area with the U.S. Food and Drug Administration (FDA). This filing represents the 5th ANDA Acella has waiting approval from the FDA, and the first filed under the leadership of Allen Fields, Acella's new VP, Head of Research and Development.
"We are pleased with the FDA's acceptance of our filing," remarked Fields. "I believe this latest filing speaks to the quality of work performed by our team, as well as to our continuous efforts to develop a strong pipeline of products for our internal and external customers."
"This filing is another example of our investment in new products and expansion of our diversified product portfolio," added Acella CEO Mark Pugh. "As always, Acella is committed to making quality healthcare more affordable for our customers."
About Acella Pharmaceuticals, LLC
Acella develops, markets, sells and distributes a broad portfolio of specialty pharmaceutical and other products in the areas of Dermatology, Women's Health, Pediatrics and other applications. Acella specializes in identifying and bringing to market quality, affordable products to customers and patients. For additional information please contact Acella at 678-325-5189.
SOURCE Acella Pharmaceuticals, LLC
Back to top
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All That Glitters: The Ultimate Gold Report".